Revelation Biosciences Inc. to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC
23 March 2022 - 12:00AM
Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or
“Revelation”), a clinical-stage life sciences company that is
focused on the development of immunologic‑based therapies for the
prevention and treatment of disease, announced today that its Chief
Executive Officer James Rolke will present a corporate overview at
the 2022 Virtual Growth Conference, presented by Maxim Group LLC
and hosted by M-Vest, on March 28th - 30th from 9:00 a.m. - 5:00
p.m. EDT.
Sign up here to access the presentation
About Revelation Biosciences Inc.
Revelation Biosciences, Inc. is a clinical-stage
life sciences company focused on the development of
immunologic-based therapies for the prevention and treatment of
disease. Revelation has several product candidates in development.
REVTx-99a, the lead therapeutic candidate, is an intranasal
immunomodulator to prevent or treat infections caused by various
respiratory viruses such as SARS-CoV-2, including its variants,
influenza A and B, parainfluenza, rhinovirus, and RSV. REVTx-99b is
being developed for other indications such as: allergic rhinitis
and chronic nasal congestion. REVTx-200 is an intranasal
immunomodulator adjunct to be used in combination with an
intramuscular vaccination for more complete immunity. REVTx-200 is
based on the same technology used in REVTx-99a and REVTx-99b. In
addition to Revelation’s therapeutic pipeline, Revelation is also
developing REVDx-501, a rapid home use diagnostic that can be used
to detect any respiratory viral infection, regardless of virus type
or strain, without the need for specialized instrumentation.
For more information on Revelation, please visit
www.RevBiosciences.com.
Company Contacts
Sandra VedrickVice President, Investor Relations & Human
ResourcesRevelation Biosciences Inc. Email:
svedrick@revbiosciences.com
and
Chester Zygmont, IIIChief Financial OfficerRevelation
Biosciences Inc. Email: czygmont@revbiosciences.com
Revelation Biosciences (NASDAQ:REVBW)
Historical Stock Chart
From May 2024 to Jun 2024
Revelation Biosciences (NASDAQ:REVBW)
Historical Stock Chart
From Jun 2023 to Jun 2024